The brain drug developer is now saying that its two marketed products could ultimately bring in $2 billion annually, and its ...

Bill Meury, who shepherded Karuna and Anthos to multibillion-dollar buyouts, will take over Incyte, a successful drug ...

Thimerosal, targeted by activists who claim it’s linked to autism, shouldn't be used in vaccines administered in the U.S. in ...